SCHEMBL23109602

SCHEMBL23109602

Bc1c(B)c(B)c2c(-c3ccc4oc5cc6ccccc6cc5c4c3)c3c(B)c(B)c(B)c(B)c3c(-c3ccc(-c4ccc(-c5ccccc5)cc4)cc3)c2c1B

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 3/20 0.35
PLA2G4A P47712 3/20 0.35
ESR1 P03372 2/20 0.34
ESR2 Q92731 2/20 0.34
KDM4E B2RXH2 3/20 0.34
HPGD P15428 3/20 0.34
MAPT P10636 2/20 0.34
TSHR P16473 2/20 0.34
HSD17B10 Q99714 2/20 0.34
PRKDC P78527 2/20 0.34
ALDH1A1 P00352 1/20 0.34
ALOX15 P16050 1/20 0.34
CASP1 P29466 1/20 0.34
CASP7 P55210 1/20 0.34
PGR P06401 1/20 0.33
CYP1A1 P04798 1/20 0.33
CYP1A2 P05177 1/20 0.33
FYN P06241 1/20 0.33
MAPK3 P27361 1/20 0.33
AHR P35869 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26019202 1.00 PLA2G2A (0.35) PLA2G2APLA2G4AESR1ESR2KDM4E
SCHEMBL21940070 0.99 PLA2G2A (0.36) PLA2G2APLA2G4AESR1ESR2KDM4E
SCHEMBL25684384 0.97 PLA2G2A (0.38) PLA2G2APLA2G4AESR1ESR2KDM4E
SCHEMBL24908330 0.96 PLA2G2A (0.37) PLA2G2APLA2G4AESR1ESR2KDM4E
SCHEMBL23109323 0.95 PLA2G2A (0.34) PLA2G2APLA2G4AESR1ESR2KDM4E
SCHEMBL26010882 0.95 PLA2G2A (0.38) PLA2G2APLA2G4AESR1ESR2KDM4E
SCHEMBL29332371 0.92 ESR1 (0.36) PLA2G2APLA2G4AESR1ESR2KDM4E
SCHEMBL25785798 0.92 PGR (0.36) PLA2G2APLA2G4AESR1ESR2KDM4E
SCHEMBL25580827 0.92 PGR (0.36) PLA2G2APLA2G4AESR1ESR2KDM4E
SCHEMBL24908172 0.91 PGR (0.38) PLA2G2APLA2G4AESR1ESR2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240023436-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2024-01-18 US disclosed
US-20230209998-A1 ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-29 US disclosed
US-20220285625-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS IDEMITSU KOSAN CO.,LTD. (JP) 2022-09-08 US disclosed
US-20210083193-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2021-03-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240023436-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE EED, EML4, ESR1 PLA2G2A 3402/4885PLA2G4A 4288/4885ESR1 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.